EMP3 and breast carcinoma: Very surprisingly, in contrast to our results, Passarelli et al. have demonstrated that LARS1 has a tumor suppressive effect by repressing the codon-dependent translation of epithelial membrane protein 3 (EMP3) and gamma-glutamyltransferase 5 (GGT5) in breast cancer [31].